Sustancias dopantes y su incidencia: una visión retrospectiva del laboratorio nacional de prevención y control del dopaje de México

Abstract

The use of banned substances to increase athletes' performance has been a scourge in international sport. In this sense, the World Anti-Doping Agency (WADA-AMA) has implemented a series of standards that harmonize the fight against doping. In particular, accredited WADA-AMA laboratories play an important role in the eradication of sports doping. This report shows the data obtained in the National Laboratory of Prevention and Control of Doping (LNPCD-CONADE) according to the incidence of Adverse Analytical Findings (AAF) in the 2009-2015 interval, which were obtained from the analysis of a total of 18,085 biological doping-control samples. The distribution of samples was analyzed as a function of gender, type of sport either in competition or out of competition, as well as the prevalence of AAF during the period of time analyzed and the relation regarding group of doping substance and type of sport. The data presented here were compared with those reported worldwide by the WADA-AMA and it was observed that in the cases of substances of the S1 group, the percentage reported by the LNPCD-CONADE is higher than the one reported worldwide. The opposite was observed for AAF presented by some substance from Groups S6 and S8. Likewise, a higher prevalence in the use of doping substances by male athletes (75%) is observed compared to that observed in female athletes (25%). The sports with the highest number of AAF detected in the laboratory were baseball, cycling, and athletics.

Sustancias dopantes y su prevalencia en el deporte chileno un estudio observacional (Doping substances and their prevalence in the chilean sport an observational study)

“…Estos hallazgos se coinciden con reportes recientes que sugieren la necesidad del deportista por obtener ventajas competitivas para sobresalir en cada uno de los eventos deportivos de alta concurrencia a través de diversas estrategias de dopaje (Yuan., 2021;Hayward., 2022;Okano., 2022). En cuanto a los niveles mínimos de rendimiento requeridos (MRPL, por sus siglas en inglés) se encuentran normados por la WADA, sin embargo, a pesar de esto los ejes básicos legislativos, biomédicos y psicosociales que conforman el sistema antidopaje han sido tardíos en su aparición, siendo esto apreciado en algunos casos donde un laboratorio puede detectar alguna sustancia con niveles por debajo del MRPL reportando el resultado analítico adverso producto de la confiabilidad analítica (Mercado Soberanes et al, 2019;García-Grimau, Casado, de la Vega., 2021). Esto permite explicar en parte la falta de consistencia entre los datos provenientes desde organismos oficiales y los autoreportes en deportistas (Mudrak., 2018;Chegeni., 2021).…”